Status:
COMPLETED
A Study of RO4995819 in Healthy Elderly Volunteers
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Healthy Volunteer
Eligibility:
All Genders
65-85 years
Phase:
PHASE1
Brief Summary
This study will evaluate the safety, tolerability and pharmacokinetics of RO4995819 in healthy elderly volunteers. Volunteers will be randomized to receive once daily doses of RO4995819 or matching pl...
Eligibility Criteria
Inclusion
- Adult healthy volunteer, 65-85 years of age
- Body Mass Index (BMI) between 18.0 to 30.0 kg/m2 inclusive and a total body weight \>50 kg (110 lbs)
- Able to participate and willing to give written informed consent and to comply with the study restrictions
Exclusion
- Any history or suspicion of drug or alcohol abuse
- Clinically significant or unstable cardiovascular or bronchopulmonary diseases, or any type of cancer
- History of liver disease
- Significant past or present neurological disorder
- History of psychiatric disorders
- Participation in an investigational drug or device study within 12 weeks prior to screening
- Donation of blood over 500 mL within three months prior to screening
Key Trial Info
Start Date :
July 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01457664
Start Date
July 1 2011
End Date
December 1 2011
Last Update
November 2 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Miramar, Florida, United States, 33025